ArticleNucleic acids research2026
Directed evolution on compact landing pads yields highly efficient recombinases for large DNA integration.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Large serine recombinase-mediated gene insertion for high-throughput screens: advantages, design principles, and applications.Nucleic acids research · 2026Review
- Prime editing updates: technological evolution, methodological expansion, and delivery strategies for in vivo applications.BMB reports · 2026Review
- From Gene Knockouts to Genome Remodeling: Large DNA Fragment Deletion Technologies in Plants.Plants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Site-specific DNA recombinases are powerful tools for genome engineering. The recent convergence of DNA recombinase-mediated technology with prime editing has established a promising new frontier for large-scale genomic integration. However, this strategy has limitations, including low intrinsic catalytic efficiency of DNA recombination enzymes and inefficiency of their long DNA landing pad insertions. To overcome these challenges, we developed a novel directed evolution strategy using progressively shortening landing pads as a selective pressure. The resulting evolved variants, VK and AVK, exhibited substantially enhanced intrinsic activity that is maintained on short-length landing pads. This enables a powerful synergistic effect with increased insertion efficiency of prime editing, leading to a dramatic increase in overall integration efficiency while maintaining high genomic specificity. This work thus provides a new class of highly efficient recombinases and a robust engineering strategy with broad applicability for both the development of gene therapies and fundamental research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.